Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3533.TW Stock Summary
Top 10 Correlated ETFs
3533.TW
In the News
3533.TW Financial details
Company Rating
Buy
Market Cap
156.42B
Income
5.59B
Revenue
24.48B
Book val./share
249.47
Cash/share
118.51
Dividend
25.18
Dividend %
2.59%
Employees
6.32K
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
18.73
Forward P/E
17.26
PEG
-14.01
P/S
4.34
P/B
4.02
P/C
11.69
P/FCF
13.8
Quick Ratio
3.19
Current Ratio
3.55
Debt / Equity
0.1
LT Debt / Equity
0.03
-
-
EPS (TTM)
50.6
EPS next Y
80.23
EPS next Q
13.92
EPS this Y
-13.29%
EPS next Y
58.56%
EPS next 5Y
95.14%
EPS last 5Y
20.5%
Revenue last 5Y
10.16%
Revenue Q/Q
1.66%
EPS Q/Q
-32.56%
-
-
-
-
SMA20
31.49%
SMA50
33.96%
SMA100
64.48%
Inst Own
-
Inst Trans
-
ROA
15%
ROE
23%
ROC
0.26%
Gross Margin
47%
Oper. Margin
32%
Profit Margin
23%
Payout
-
Shs Outstand
111.33M
Shs Float
101.06M
-
-
-
-
Target Price
-
52W Range
693.0-1420.0
52W High
-2.46%
52W Low
+99.86%
RSI
72
Rel Volume
0.69
Avg Volume
1.52M
Volume
1.05M
Perf Week
5.73%
Perf Month
40.04%
Perf Quarter
67.47%
Perf Half Y
65.87%
-
-
-
-
Beta
0.331
-
-
Volatility
39.55%, 140.58%
Prev Close
-1.07%
Price
1385
Change
-1.07%
3533.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 144.9 | 166.29 | 204.29 | 253.12 | 221.74 | |
Net income per share | 19.94 | 26.28 | 33.16 | 58.42 | 50.65 | |
Operating cash flow per share | 32.26 | 33.36 | 25.69 | 72.23 | 82.74 | |
Free cash flow per share | 20.93 | 15.52 | -9.97 | 37.6 | 58.32 | |
Cash per share | 29.7 | 30.41 | 33.03 | 66.97 | 119.49 | |
Book value per share | 113.46 | 129.82 | 161.03 | 213.03 | 251.53 | |
Tangible book value per share | 119.51 | 137.75 | 170.46 | 227.22 | 266.09 | |
Share holders equity per share | 113.46 | 129.82 | 161.03 | 213.03 | 251.53 | |
Interest debt per share | 2.18 | 2.14 | 25.31 | 24.65 | 24.63 | |
Market cap | 33.58B | 49.34B | 79.69B | 88.43B | 118.15B | |
Enterprise value | 30.94B | 46.59B | 79.01B | 83.93B | 108.15B | |
P/E ratio | 16.18 | 18.06 | 22.95 | 14.14 | 21.12 | |
Price to sales ratio | 2.23 | 2.85 | 3.73 | 3.26 | 4.83 | |
POCF ratio | 10 | 14.22 | 29.63 | 11.44 | 12.93 | |
PFCF ratio | 15.41 | 30.58 | -76.36 | 21.97 | 18.35 | |
P/B Ratio | 2.84 | 3.66 | 4.73 | 3.88 | 4.25 | |
PTB ratio | 2.84 | 3.66 | 4.73 | 3.88 | 4.25 | |
EV to sales | 2.05 | 2.69 | 3.69 | 3.1 | 4.42 | |
Enterprise value over EBITDA | 7.95 | 9.67 | 12.88 | 7.98 | 11.59 | |
EV to operating cash flow | 9.21 | 13.43 | 29.37 | 10.85 | 11.84 | |
EV to free cash flow | 14.2 | 28.88 | -75.71 | 20.85 | 16.79 | |
Earnings yield | 0.06 | 0.06 | 0.04 | 0.07 | 0.05 | |
Free cash flow yield | 0.06 | 0.03 | -0.01 | 0.05 | 0.05 | |
Debt to equity | 0.02 | 0.02 | 0.16 | 0.11 | 0.1 | |
Debt to assets | 0.01 | 0.01 | 0.1 | 0.08 | 0.07 | |
Net debt to EBITDA | -0.68 | -0.57 | -0.11 | -0.43 | -1.07 | |
Current ratio | 3.14 | 2.85 | 2.42 | 2.73 | 3.8 | |
Interest coverage | 125.81 | 197.6 | 161.76 | 149.72 | 97.67 | |
Income quality | 1.19 | 0.95 | 0.59 | 0.94 | 1.63 | |
Dividend Yield | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | |
Payout ratio | 0.43 | 0.4 | 0.4 | 0.27 | 0.5 | |
Sales general and administrative to revenue | 0.07 | 0.06 | 0.07 | 0.06 | 0 | |
Research and developement to revenue | 0.07 | 0.08 | 0.09 | 0.08 | 0.09 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | -0.35 | -0.53 | -1.39 | -0.48 | -0.3 | |
Capex to revenue | -0.08 | -0.11 | -0.17 | -0.14 | -0.11 | |
Capex to depreciation | -1.14 | -1.63 | -2.4 | -1.63 | -1.13 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 225.6 | 277.04 | 346.62 | 529.16 | 535.42 | |
ROIC | 0.18 | 0.2 | 0.18 | 0.25 | 0.17 | |
Return on tangible assets | 0.13 | 0.14 | 0.13 | 0.19 | 0.15 | |
Graham Net | 48.85 | 49.37 | 40.02 | 81.07 | 122.62 | |
Working capital | 7.77B | 8.47B | 9.96B | 13.99B | 19.22B | |
Tangible asset value | 12.45B | 14.32B | 17.85B | 24.33B | 29.23B | |
Net current asset value | 7.67B | 8.25B | 8.6B | 13.3B | 17.5B | |
Invested capital | 0.02 | 0.02 | 0.16 | 0.11 | 0.1 | |
Average receivables | 5.97B | 6.82B | 8.36B | 10.38B | 10.74B | |
Average payables | 1.81B | 2.19B | 2.56B | 2.48B | 2.09B | |
Average inventory | 2.1B | 2.27B | 3.33B | 3.83B | 3.11B | |
Days sales outstanding | 152.92 | 154.67 | 160.4 | 152.95 | 150.84 | |
Days payables outstanding | 71.52 | 88.11 | 74.32 | 56.61 | 48.66 | |
Days of inventory on hand | 74.97 | 90.15 | 116.35 | 85.73 | 70.94 | |
Receivables turnover | 2.39 | 2.36 | 2.28 | 2.39 | 2.42 | |
Payables turnover | 5.1 | 4.14 | 4.91 | 6.45 | 7.5 | |
Inventory turnover | 4.87 | 4.05 | 3.14 | 4.26 | 5.15 | |
ROE | 0.18 | 0.2 | 0.21 | 0.27 | 0.2 | |
Capex per share | -11.34 | -17.84 | -35.65 | -34.64 | -24.42 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 65.25 | 53.11 | 51.49 | 58.04 | 59.02 | |
Net income per share | 13.48 | 10.96 | 11.56 | 16.77 | 11.31 | |
Operating cash flow per share | 25.41 | 28.62 | 18.75 | 23.25 | 12.35 | |
Free cash flow per share | 18.32 | 23.53 | 11.99 | 18.02 | 5.04 | |
Cash per share | 66.52 | 111.26 | 108.25 | 113.43 | 118.51 | |
Book value per share | 211.6 | 243.47 | 221.51 | 242.17 | 249.47 | |
Tangible book value per share | 225.7 | 258.11 | 233.6 | 254.96 | 263.91 | |
Share holders equity per share | 211.6 | 243.47 | 221.51 | 242.17 | 249.47 | |
Interest debt per share | 24.12 | 30.84 | 16.6 | 29.19 | 23.98 | |
Market cap | 89.03B | 98.99B | 95.57B | 93.54B | 119.12B | |
Enterprise value | 84.52B | 90.38B | 85.43B | 84.2B | 109.13B | |
P/E ratio | 15.32 | 20.94 | 18.6 | 12.52 | 23.65 | |
Price to sales ratio | 12.66 | 17.29 | 16.7 | 14.47 | 18.13 | |
POCF ratio | 32.51 | 32.07 | 45.87 | 36.13 | 86.63 | |
PFCF ratio | 45.09 | 39.01 | 71.75 | 46.61 | 212.12 | |
P/B Ratio | 3.9 | 3.77 | 3.88 | 3.47 | 4.29 | |
PTB ratio | 3.9 | 3.77 | 3.88 | 3.47 | 4.29 | |
EV to sales | 12.02 | 15.78 | 14.93 | 13.03 | 16.61 | |
Enterprise value over EBITDA | 32.62 | 41.86 | 33.31 | 28.08 | 42.67 | |
EV to operating cash flow | 30.86 | 29.28 | 41 | 32.52 | 79.36 | |
EV to free cash flow | 42.81 | 35.62 | 64.14 | 41.95 | 194.32 | |
Earnings yield | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | |
Free cash flow yield | 0.02 | 0.03 | 0.01 | 0.02 | 0 | |
Debt to equity | 0.11 | 0.13 | 0.07 | 0.12 | 0.1 | |
Debt to assets | 0.08 | 0.09 | 0.05 | 0.09 | 0.07 | |
Net debt to EBITDA | -1.74 | -3.99 | -3.95 | -3.11 | -3.91 | |
Current ratio | 2.73 | 3.61 | 3.05 | 3.55 | 3.8 | |
Interest coverage | 123.18 | 82.76 | 122.57 | 155.25 | 94.63 | |
Income quality | 1.39 | 2.01 | 1.08 | 1.08 | 1.09 | |
Dividend Yield | 0 | 0 | 0 | 0.03 | 0 | |
Payout ratio | 0 | 0 | 0 | 1.5 | 0 | |
Sales general and administrative to revenue | 0.06 | 0.07 | 0.06 | 0.07 | 0 | |
Research and developement to revenue | 0.08 | 0.09 | 0.09 | 0.08 | 0.09 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.28 | -0.18 | -0.36 | -0.22 | -0.59 | |
Capex to revenue | -0.11 | -0.1 | -0.13 | -0.09 | -0.12 | |
Capex to depreciation | -1.27 | -0.9 | -1.21 | -0.98 | -1.44 | |
Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Graham number | 253.3 | 245 | 240.03 | 302.29 | 251.99 | |
ROIC | 0.06 | 0.04 | 0.05 | 0.06 | 0.05 | |
Return on tangible assets | 0.04 | 0.03 | 0.04 | 0.05 | 0.03 | |
Graham Net | 80.53 | 112.03 | 96.55 | 113.39 | 121.61 | |
Working capital | 13.99B | 17.98B | 16.32B | 18.4B | 19.22B | |
Tangible asset value | 24.33B | 27.83B | 25.96B | 28.39B | 29.23B | |
Net current asset value | 13.3B | 16.06B | 14.46B | 16.53B | 17.5B | |
Invested capital | 0.11 | 0.13 | 0.07 | 0.12 | 0.1 | |
Average receivables | 11.38B | 10.6B | 9.7B | 9.96B | 10.24B | |
Average payables | 2.23B | 2.01B | 1.57B | 1.64B | 1.81B | |
Average inventory | 3.55B | 3.29B | 2.85B | 2.65B | 2.64B | |
Days sales outstanding | 145.32 | 154.6 | 150.48 | 144.29 | 138.58 | |
Days payables outstanding | 58.05 | 47.82 | 42.62 | 47.54 | 46.3 | |
Days of inventory on hand | 87.91 | 87.1 | 76.89 | 69.41 | 67.49 | |
Receivables turnover | 0.62 | 0.58 | 0.6 | 0.62 | 0.65 | |
Payables turnover | 1.55 | 1.88 | 2.11 | 1.89 | 1.94 | |
Inventory turnover | 1.02 | 1.03 | 1.17 | 1.3 | 1.33 | |
ROE | 0.06 | 0.05 | 0.05 | 0.07 | 0.05 | |
Capex per share | -7.09 | -5.09 | -6.76 | -5.23 | -7.31 |
3533.TW Frequently Asked Questions
What is Lotes Co., Ltd stock symbol ?
Lotes Co., Ltd is a TW stock and trading under the symbol 3533.TW
What is Lotes Co., Ltd stock quote today ?
Lotes Co., Ltd stock price is $1385 today.
Is Lotes Co., Ltd stock public?
Yes, Lotes Co., Ltd is a publicly traded company.